西B

Nancy L Bartlett1, Uwe Hahn2, Won-Seog Kim3

  • 1Division of Oncology, Washington University School of Medicine, Siteman Cancer Center, St Louis, MO.

概括

布伦图西马布维多丁加上莱纳利多米德和瑞图西马布显著改善了复发或耐药的扩散大B细胞淋巴瘤患者的整体存活率. 这种组合疗法在重度预治疗的个体中显示出可管理的安全性.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K